A Cohort Study of Stereotactic Radiosurgery Results for Patients With 5 to 15 Versus 2 to 4 Brain Metastatic Tumors

A Cohort Study of Stereotactic Radiosurgery Results for Patients With 5 to 15 Versus 2 to 4 Brain Metastatic Tumors

Purpose: The role of stereotactic radiosurgery (SRS) alone for patients with ≥5 brain metastases is not fully understood. The objective of the study was to compare SRS-alone treatment results for 2 to 4 versus 5 to 15 tumors. Methods and Materials: This was an institutional review board–approved, re...

Full description

Bibliographic Details
Main Authors:	Masaaki Yamamoto, MD, PhD, Yasunori Sato, PhD, Yoshinori Higuchi, MD, PhD, Hidetoshi Kasuya, MD, PhD, Bierta E. Barfod, MD
Format:	Article
Language:	English
Published:	Elsevier 2020-05-01
Series:	Advances in Radiation Oncology
Online Access:	http://www.sciencedirect.com/science/article/pii/S2452109419301654

Similar Items

Single fraction stereotactic radiosurgery for multiple brain metastases
by: Dror Limon, MD, et al.
Published: (2017-10-01)

The Effect of Slice Thickness on Contours of Brain Metastases for Stereotactic Radiosurgery
by: Sara L. Thrower, PhD, et al.
Published: (2021-07-01)

Efficacy and Safety of Primary Stereotactic Radiosurgery in Patients With Intraventricular Meningiomas
by: Sebastian M. Christ, MD, PhD, et al.
Published: (2023-01-01)

Early Detection of Leptomeningeal Metastases Among Patients Undergoing Spinal Stereotactic Radiosurgery
by: Morgan E. Freret, MD, PhD, et al.
Published: (2023-03-01)

Outcomes in Patients with Intact and Resected Brain Metastasis Treated with 5-Fraction Stereotactic Radiosurgery
by: David J. Carpenter, MD, et al.
Published: (2023-03-01)

Conventional Radiotherapy and Stereotactic Radiosurgery in the Management of Metastatic Spine Disease
by: Hao-ran Zhang MD, et al.
Published: (2020-08-01)

Stereotactic Radiosurgery for Brain Metastases in Patients With Small Cell Lung Cancer
by: Victoria H. Wang, BS, et al.
Published: (2023-09-01)

Rodent Model of Brain Radionecrosis Using Clinical LINAC-Based Stereotactic Radiosurgery
by: Sean P. Devan, MS, et al.
Published: (2022-11-01)

Plan Assessment Metrics for Dose Painting in Stereotactic Radiosurgery
by: Benjamin Z. Tham, MSc, et al.
Published: (2023-11-01)

Radiation Therapy Practice Patterns for Brain Metastases in the United States in the Stereotactic Radiosurgery Era
by: Andrew B. Barbour, PhD, et al.
Published: (2020-01-01)

Single-Isocenter Multitarget Stereotactic Radiosurgery Is Safe and Effective in the Treatment of Multiple Brain Metastases
by: Joshua D. Palmer, MD, et al.
Published: (2020-01-01)

How Does the Number of Brain Metastases Correlate With Normal Brain Exposure in Single-Isocenter Multitarget Multifraction Stereotactic Radiosurgery
by: Dandan Zheng, PhD, et al.
Published: (2024-06-01)

Hippocampal Dosimetry and the Necessity of Hippocampal-Sparing in Gamma Knife Stereotactic Radiosurgery for Extensive Brain Metastases
by: Matthew D. Riina, BS, et al.
Published: (2020-03-01)

Outcomes in Patients With 4 to 10 Brain Metastases Treated With Dose-Adapted Single-Isocenter Multitarget Stereotactic Radiosurgery: A Prospective Study
by: Grace J. Kim, MD, PhD, et al.
Published: (2021-11-01)

Effect of Target Changes on Target Coverage and Dose to the Normal Brain in Fractionated Stereotactic Radiation Therapy for Metastatic Brain Tumors
by: Hideharu Miura, PhD, et al.
Published: (2023-11-01)

Nivolumab and Stereotactic Radiosurgery for Patients With Breast Cancer Brain Metastases: A Nonrandomized, Open-Label Phase 1b Study
by: Kamran A. Ahmed, MD, et al.
Published: (2021-11-01)

Automated Planning for Prostate Stereotactic Body Radiation Therapy on the 1.5 T MR-Linac
by: Stefania Naccarato, PhD, et al.
Published: (2022-05-01)

Cognitive effects of stereotactic radiosurgery in adult patients with brain metastases: A systematic review
by: Wietske C.M. Schimmel, MSc, et al.
Published: (2018-10-01)

Management of Adverse Radiation Effect Associated with Stereotactic Radiosurgery of Brain Metastasis in Multiple Sclerosis
by: Elisa K. Liu, BS, et al.
Published: (2023-03-01)

Preoperative Dural Contact and Recurrence Risk After Surgical Cavity Stereotactic Radiosurgery for Brain Metastases: New Evidence in Support of Consensus Guidelines
by: Matthew Susko, MD, et al.
Published: (2019-07-01)

Dosimetric Analysis of Intra-Fraction Motion Detected by Surface-Guided Radiation Therapy During Linac Stereotactic Radiosurgery
by: Ryan D. Foster, PhD, et al.
Published: (2023-05-01)

Stereotactic Radiosurgery in the Management of Brain Metastases: A Case-Based Radiosurgery Society Practice Guideline
by: Colton Ladbury, MD, et al.
Published: (2024-03-01)

Recent Advances and Challenges in Stereotactic Body Radiotherapy
by: Atsuto Katano MD, PhD, et al.
Published: (2024-02-01)

Factors Associated With New-Onset Seizures Following Stereotactic Radiosurgery for Newly Diagnosed Brain Metastases
by: Emily C. Lerner, BA, et al.
Published: (2022-11-01)

Internal dose escalation is associated with increased local control for non-small cell lung cancer (NSCLC) brain metastases treated with stereotactic radiosurgery (SRS)
by: Christopher Abraham, MD, et al.
Published: (2018-04-01)

Pretreatment Spatially Aware Magnetic Resonance Imaging Radiomics Can Predict Distant Brain Metastases (DBMs) After Stereotactic Radiosurgery/Radiation Therapy (SRS/SRT)
by: Joseph Bae, MS, et al.
Published: (2024-05-01)

Tufts Medical Center Experience With Long-Term Follow-Up of Vestibular Schwannoma Treated With Gamma Knife Stereotactic Radiosurgery: Novel Finding of Delayed Pseudoprogression
by: Justin Wage, MD, et al.
Published: (2021-07-01)

Tumor Lysis Syndrome in a Patient With Metastatic Endometrial Cancer Treated With Lattice Stereotactic Body Radiation Therapy
by: Joshua P. Schiff, MD, et al.
Published: (2022-01-01)

Interinstitutional Plan Quality Assessment of 2 Linac-Based, Single-Isocenter, Multiple Metastasis Radiosurgery Techniques
by: Haisong Liu, PhD, et al.
Published: (2020-09-01)

Ramucirumab Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Untreated Metastatic EGFR-Mutated NSCLC: RELAY Japanese Subset
by: Kazuto Nishio, MD, PhD, et al.
Published: (2021-06-01)

Feasibility and safety of cavity-directed stereotactic radiosurgery for brain metastases at a high-volume medical center
by: Paul Rava, MD PhD, et al.
Published: (2016-07-01)

Distant intracranial failure in melanoma brain metastases treated with stereotactic radiosurgery in the era of immunotherapy and targeted agents
by: Sahaja Acharya, MD, et al.
Published: (2017-10-01)

Vestibular Schwannoma: Results of Hypofractionated Stereotactic Radiation Therapy
by: Pierre-Marie Pialat, MD, et al.
Published: (2021-07-01)

Simulation of an HDR “Boost” with Stereotactic Proton versus Photon Therapy in Prostate Cancer: A Dosimetric Feasibility Study
by: Jill S. Remick, MD, et al.
Published: (2020-11-01)

Spatially fractionated stereotactic body radiation therapy (Lattice) for large tumors
by: Sai Duriseti, MD, PhD, et al.
Published: (2021-05-01)

Magnetic Resonance-Guided Stereotactic Body Radiation Therapy/Hypofractionated Radiation therapy for Metastatic and Primary Central and Ultracentral Lung Lesions
by: Maria L. Sandoval, MD, MS, et al.
Published: (2023-05-01)

Impact of Stereotactic Body Radiotherapy on Thrombin Generation and Platelet Aggregation in Patients with Non-Small Cell Lung Cancer
by: Kristian Kirkelund Bentsen MD, et al.
Published: (2023-11-01)

18F-FDG PET response and clinical outcomes after stereotactic body radiation therapy for metastatic melanoma
by: Ryan S. Youland, MD, et al.
Published: (2017-04-01)

Stereotactic Versus Conventional Radiation Therapy for Patients With Pancreatic Cancer in the Modern Era
by: Joseph Abi Jaoude, MD, et al.
Published: (2021-11-01)

Brain metastases with poor vascular function are susceptible to pseudoprogression after stereotactic radiation surgery
by: Ingrid Digernes, MSc, et al.
Published: (2018-10-01)